Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway

PURPOSE: In Norway, blood donors using antihypertensive medication were deferred until 2015. Following revision of the national directive, these donors could be allowed, providing stable dose for at least 3 months, adequate blood pressure control and no adverse effects caused by the therapy. The new...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnsen, Kathrine M Neuman, Magnussen, Karin, Erstad, Christian, Bhatti, Sadaf Nabi, Nissen-Meyer, Lise Sofie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164375/
https://www.ncbi.nlm.nih.gov/pubmed/37163174
http://dx.doi.org/10.2147/JBM.S390609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164375/
https://www.ncbi.nlm.nih.gov/pubmed/37163174
http://dx.doi.org/10.2147/JBM.S390609

Ejemplares similares